Article Text

Download PDFPDF
Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial

Footnotes

  • Patient consent Parental/guardian consent obtained.

  • Funding This study was supported by a grant from the Bath Unit for Research in Paediatrics (BURP) that included support from Cow and Gate and Bishopsgate Financial Management. FJKO'C was supported by the Wellcome Trust, ALL and EH by Cow and Gate and KD and JPO by BURP. The funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report.

  • The work was carried out in Royal United Hospital Bath NHS Trust and the School for Health, the University of Bath.

  • Competing interests JPO unsuccessfully approached Aventis for funding of a follow-up study to investigate visual field defects and appeared in a promotional video about vigabatrin for Hoechst-Marion-Roussel. ALL received funding from Hoechst-Marion-Roussel to attend a conference. All other authors have no conflict of interest.

  • Ethics approval This study was conducted with the approval of the South West MREC.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Patient consent Parental/guardian consent obtained.

  • Funding This study was supported by a grant from the Bath Unit for Research in Paediatrics (BURP) that included support from Cow and Gate and Bishopsgate Financial Management. FJKO'C was supported by the Wellcome Trust, ALL and EH by Cow and Gate and KD and JPO by BURP. The funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report.

  • The work was carried out in Royal United Hospital Bath NHS Trust and the School for Health, the University of Bath.

  • Competing interests JPO unsuccessfully approached Aventis for funding of a follow-up study to investigate visual field defects and appeared in a promotional video about vigabatrin for Hoechst-Marion-Roussel. ALL received funding from Hoechst-Marion-Roussel to attend a conference. All other authors have no conflict of interest.

  • Ethics approval This study was conducted with the approval of the South West MREC.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.